3//SEC Filing
Valor IV Pharma Holdings, LLC 3
Accession 0000899243-20-022867
CIK 0001802665other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 9:48 PM ET
Size
24.4 KB
Accession
0000899243-20-022867
Insider Transaction Report
Form 3
Valor IV Pharma Holdings, LLC
10% Owner
Holdings
- 845,336
Common Stock
Series A Preferred Stock
→ Common Stock (9,129,640 underlying)Series C Preferred Stock
→ Common Stock (217,527 underlying)
Sabater Juan A.
Director
Holdings
Series A Preferred Stock
→ Common Stock (9,129,640 underlying)Series C Preferred Stock
→ Common Stock (217,527 underlying)- 845,336
Common Stock
Gracias Antonio J.
Director
Holdings
- 845,336
Common Stock
Series A Preferred Stock
→ Common Stock (9,129,640 underlying)Series C Preferred Stock
→ Common Stock (217,527 underlying)
Footnotes (3)
- [F1]Antonio Gracias is the Chief Executive Officer of Valor Management L.P. ("Valor Management") and Juan A. Sabater is the President of Valor Management. Valor Management is the managing member of Valor Equity Capital IV LLC, which is the general partner of Valor Equity Associates IV L.P., which, in turn, is the general partner of each of Valor Equity Partners IV L.P., Valor Equity Partners IV-A L.P. and Valor Equity Partners IV-B L.P. (collectively, the "Valor Funds"). The Valor Funds are the sole members of the Valor IV Pharma Holdings, LLC ("Valor"). As such, Messers. Gracias and Sabater may be deemed to beneficially own the shares held by Valor. Each of Messers. Gracias and Sabater disclaims beneficial ownership over the shares described herein except to the extent of their pecuniary interest therein.
- [F2]The Series A Preferred Stock is convertible into Common Stock on a 8.215-for-1 basis into the number of shares of Common Stock as shown in Column 3 at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. These shares have no expiration date.
- [F3]The Series C Preferred Stock is convertible into Common Stock on a 8.215-for-1 basis into the number of shares of Common Stock as shown in Column 3 at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. These shares have no expiration date.
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001821186
Filing Metadata
- Form type
- 3
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 9:48 PM ET
- Size
- 24.4 KB